(1.30%) 5 129.97 points
(1.25%) 38 705 points
(2.03%) 16 162 points
(-0.89%) $78.25
(5.31%) $2.14
(0.03%) $2 310.30
(-0.42%) $26.72
(0.37%) $966.15
(-0.35%) $0.929
(-1.24%) $10.86
(-0.11%) $0.797
(0.38%) $91.47
Live Chart Being Loaded With Signals
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease...
Stats | |
---|---|
今日成交量 | 349 445 |
平均成交量 | 47 812.00 |
市值 | 8.98M |
EPS | $0 ( 2024-03-22 ) |
下一个收益日期 | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.619 |
ATR14 | $0.214 (3.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Tanner John William | Buy | 32 000 | Stock Option (Right to Buy) |
2023-11-09 | Gregoire Sylvie | Sell | 10 000 | Common Stock |
2023-11-09 | Alam John J | Sell | 12 500 | Common Stock |
2023-09-15 | Cobuzzi Robert Joseph Jr. | Buy | 16 000 | Stock Option (Right to Buy) |
2023-09-15 | Tanner John William | Buy | 16 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
44.89 |
Last 93 transactions |
Buy: 1 964 449 | Sell: 147 821 |
音量 相关性
Diffusion Pharmaceuticals 相关性
10 最负相关 | |
---|---|
CREX | -0.971 |
DVCR | -0.959 |
AVEO | -0.958 |
KVSC | -0.956 |
TIOAU | -0.955 |
NVCN | -0.955 |
BNIXU | -0.954 |
LFST | -0.952 |
AMYT | -0.951 |
ITMR | -0.949 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Diffusion Pharmaceuticals 相关性 - 货币/商品
Diffusion Pharmaceuticals 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-7.46 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-7.46 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-12.50 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-15.00 |
Financial Reports:
No articles found.
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。